Current Status of Aspirin User in Korean Diabetic Patients Using Korean Health Insurance Database
Open Access
- 1 January 2006
- journal article
- Published by Korean Diabetes Association in The Journal of Korean Diabetes Association
- Vol. 30 (5) , 363-371
- https://doi.org/10.4093/jkda.2006.30.5.363
Abstract
Park IB, et al. J Korean Diabetes Assoc. 2006 Sep;30(5):363-371. https://doi.org/10.4093/jkda.2006.30.5.363Keywords
This publication has 14 references indexed in Scilit:
- Prevalence of Diabetes and Impaired Fasting Glucose in KoreaDiabetes Care, 2006
- Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular eventsThe American Journal of Medicine, 2004
- Application of U.S. guidelines in other countries: Aspirin for the primary prevention of cardiovascular events in JapanThe American Journal of Medicine, 2004
- The Platelet in DiabetesDiabetes Care, 2003
- Aspirin Use and Counseling About Aspirin Among Patients With DiabetesDiabetes Care, 2002
- Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and RationaleAnnals of Internal Medicine, 2002
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Aspirin Effects on Mortality and Morbidity in Patients With Diabetes MellitusJAMA, 1992